DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,156,394 | +12.7% | 4,661 | +9.0% | 0.13% | +18.3% |
Q2 2023 | $1,026,000 | +0.1% | 4,275 | +5.2% | 0.11% | -9.2% |
Q1 2023 | $1,024,543 | +1.0% | 4,065 | +6.3% | 0.12% | -4.0% |
Q4 2022 | $1,014,701 | -22.3% | 3,823 | -24.4% | 0.12% | -43.2% |
Q3 2022 | $1,306,000 | +3.6% | 5,055 | +1.6% | 0.22% | +5.8% |
Q2 2022 | $1,261,000 | +82.8% | 4,973 | +111.3% | 0.21% | +96.2% |
Q1 2022 | $690,000 | -11.8% | 2,354 | -1.0% | 0.11% | -10.9% |
Q4 2021 | $782,000 | +22.4% | 2,378 | +13.3% | 0.12% | -28.7% |
Q3 2021 | $639,000 | +14.9% | 2,099 | +1.3% | 0.17% | +34.7% |
Q2 2021 | $556,000 | +20.9% | 2,073 | +1.5% | 0.12% | +19.2% |
Q1 2021 | $460,000 | +4.8% | 2,043 | +3.3% | 0.10% | -2.8% |
Q4 2020 | $439,000 | +5.5% | 1,977 | +2.4% | 0.11% | -7.0% |
Q3 2020 | $416,000 | +15.9% | 1,931 | -5.0% | 0.12% | +7.5% |
Q2 2020 | $359,000 | +35.5% | 2,032 | +6.1% | 0.11% | +7.0% |
Q1 2020 | $265,000 | -18.7% | 1,915 | -9.9% | 0.10% | -11.5% |
Q4 2019 | $326,000 | +7.6% | 2,126 | +1.4% | 0.11% | -0.9% |
Q3 2019 | $303,000 | +1.0% | 2,097 | -0.4% | 0.11% | -1.7% |
Q2 2019 | $300,000 | +9.1% | 2,105 | +1.0% | 0.12% | +6.4% |
Q1 2019 | $275,000 | +29.7% | 2,085 | +1.4% | 0.11% | +4.8% |
Q4 2018 | $212,000 | – | 2,057 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |